Provider-guided therapy helps review: Whether peptide therapy is appropriate Whether hormone therapy or TRT evaluation is more relevant Baseline labs and follow-up monitoring Product quality and sourcing concerns Dose, timing, and treatment length Side effects and when to stop Health conditions that may increase risk Whether another treatment path is safer Medical guidance helps patients avoid guessing and keeps performance support tied to long-term health, not just short-term muscle gain
Resets stressed cells and tissues Metabolic and oxidative stress quietly age skin, muscle, and organs long before the calendar does
Both are multi-agonist medications, but retatrutide activates three receptors (GLP-1 + GIP + glucagon) while tirzepatide activates two (GLP-1 + GIP)
Always combine with physical activity
We examined reports of GLP-1 RA-induced psychiatric AEs using the entire FAERS database as a comparator, detailing the real-world reporting of such AEs and the corresponding clinical characteristics
Given the new $349 cash-pay pricing, some patients may find it simpler to pay cash rather than navigate the patient assistance application process